KIORA PHARMACEUTICALS, INC. Operating Cash Flow
KIORA PHARMACEUTICALS, INC. (KPRX) reported Operating Cash Flow of -$5.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.89M.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.16M.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.18M.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.27M, a 238.37% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$9.96M, a 216.38% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2024 was $8.56M.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$9.56M.
- KIORA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$10.43M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$5.05M 10-Q · filed 2026-08-07 | -$7.23M derived: sum of 3 quarters · filed 2026-08-07 | -$8.51M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | -$3.16M 10-Q · filed 2026-05-08 | -$5.34M derived: sum of 2 quarters · filed 2026-05-08 | -$6.61M derived: sum of 3 quarters · filed 2026-05-08 | -$10.42M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | -$2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$3.45M derived: sum of 2 quarters · filed 2026-03-25 | -$7.26M derived: sum of 3 quarters · filed 2026-08-07 | -$9.96M 10-K · filed 2026-03-25 | |||
| 2025-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$5.08M derived: sum of 2 quarters · filed 2026-08-07 | -$7.78M 10-Q · filed 2025-11-07 | -$10.03M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | -$3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$6.51M 10-Q · filed 2026-08-07 | -$8.76M derived: sum of 3 quarters · filed 2026-08-07 | -$7.84M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | -$2.70M 10-Q · filed 2026-05-08 | -$4.96M derived: sum of 2 quarters · filed 2026-05-08 | -$4.04M derived: sum of 3 quarters · filed 2026-05-08 | -$7.77M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$1.33M derived: sum of 2 quarters · filed 2026-03-25 | -$5.07M derived: sum of 3 quarters · filed 2026-03-25 | $8.56M 10-K · filed 2026-03-25 | |||
| 2024-09-30 | $920.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$2.81M derived: sum of 2 quarters · filed 2025-11-07 | $10.81M 10-Q · filed 2025-11-07 | $8.23M derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | -$3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $9.89M 10-Q · filed 2025-08-08 | $7.31M derived: sum of 3 quarters · filed 2025-08-08 | $4.79M derived: sum of 4 quarters · filed 2025-08-08 | |||
| 2024-03-31 | $13.62M 10-Q · filed 2025-05-09 | $11.04M derived: sum of 2 quarters · filed 2025-05-09 | $8.52M derived: sum of 3 quarters · filed 2025-05-09 | $7.14M derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | -$2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$5.10M derived: sum of 2 quarters · filed 2025-03-25 | -$6.49M derived: sum of 3 quarters · filed 2025-03-25 | -$9.56M 10-K · filed 2025-03-25 | |||
| 2023-09-30 | -$2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$3.91M derived: sum of 2 quarters · filed 2024-11-08 | -$6.98M 10-Q · filed 2024-11-08 | -$9.10M derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | -$1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$4.45M 10-Q · filed 2024-08-09 | -$6.58M derived: sum of 3 quarters · filed 2024-08-09 | -$9.55M derived: sum of 4 quarters · filed 2024-08-09 | |||
| 2023-03-31 | -$3.07M 10-Q · filed 2024-05-10 | -$5.20M derived: sum of 2 quarters · filed 2024-05-10 | -$8.17M derived: sum of 3 quarters · filed 2024-05-10 | -$10.67M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -$2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$5.10M derived: sum of 2 quarters · filed 2024-03-25 | -$7.60M derived: sum of 3 quarters · filed 2024-03-25 | -$10.43M 10-K · filed 2024-03-25 | |||
| 2022-09-30 | -$2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$5.47M derived: sum of 2 quarters · filed 2023-11-09 | -$8.30M 10-Q · filed 2023-11-09 | -$11.22M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$5.33M 10-Q · filed 2023-08-08 | -$5.33M 10-Q · filed 2022-08-12 | -$8.25M derived: sum of 3 quarters · filed 2023-08-08 | -$10.52M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | -$2.83M 10-Q · filed 2023-05-09 | -$5.75M derived: sum of 2 quarters · filed 2023-05-09 | -$8.02M derived: sum of 3 quarters · filed 2023-05-09 | -$10.94M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -$2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$5.19M derived: sum of 2 quarters · filed 2023-03-23 | -$8.11M derived: sum of 3 quarters · filed 2023-03-23 | -$10.68M 10-K · filed 2023-03-23 | -$10.89M 10-K · filed 2022-04-15 | ||
| 2021-09-30 | -$2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$5.19M derived: sum of 2 quarters · filed 2022-11-09 | -$7.76M 10-Q · filed 2022-11-09 | -$7.48M 10-Q · filed 2021-11-15 | -$9.47M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -$2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$5.49M 10-Q · filed 2022-08-12 | -$5.21M 10-Q · filed 2021-08-12 | -$7.20M derived: sum of 3 quarters · filed 2022-08-12 | -$8.94M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | -$2.57M 10-Q · filed 2022-07-08 | -$4.28M derived: sum of 2 quarters · filed 2022-07-08 | -$6.02M derived: sum of 3 quarters · filed 2022-07-08 | -$7.49M derived: sum of 4 quarters · filed 2022-07-08 | |||
| 2020-12-31 | -$1.71M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | -$3.45M derived: sum of 2 quarters · filed 2022-07-07 | -$4.92M derived: sum of 3 quarters · filed 2022-07-07 | -$7.32M 10-K/A · filed 2022-07-07 | |||
| 2020-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$3.21M derived: sum of 2 quarters · filed 2021-11-15 | -$5.61M 10-Q · filed 2021-11-15 | -$8.19M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$3.87M 10-Q · filed 2021-08-12 | -$6.45M derived: sum of 3 quarters · filed 2021-08-12 | -$8.45M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$2.40M 10-Q · filed 2021-05-12 | -$4.99M derived: sum of 2 quarters · filed 2021-05-12 | -$6.99M derived: sum of 3 quarters · filed 2021-05-12 | -$8.41M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | -$2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$4.58M derived: sum of 2 quarters · filed 2021-03-25 | -$6.01M derived: sum of 3 quarters · filed 2021-03-25 | -$8.15M 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$3.42M derived: sum of 2 quarters · filed 2020-11-09 | -$5.57M 10-Q · filed 2020-11-09 | -$7.57M derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | -$1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$3.57M 10-Q · filed 2020-08-06 | -$5.57M derived: sum of 3 quarters · filed 2020-08-06 | -$8.35M derived: sum of 4 quarters · filed 2020-08-06 | |||
| 2019-03-31 | -$2.15M 10-Q · filed 2020-05-06 | -$4.15M derived: sum of 2 quarters · filed 2020-05-06 | -$6.93M derived: sum of 3 quarters · filed 2020-05-06 | -$8.88M derived: sum of 4 quarters · filed 2020-05-06 | |||
| 2018-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -$4.78M derived: sum of 2 quarters · filed 2020-03-04 | -$6.73M derived: sum of 3 quarters · filed 2020-03-04 | -$10.84M 10-K · filed 2020-03-04 | |||
| 2018-09-30 | -$2.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$4.73M derived: sum of 2 quarters · filed 2019-11-07 | -$8.84M 10-Q · filed 2019-11-07 | -$10.29M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | -$1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$6.06M 10-Q · filed 2019-08-08 | -$7.51M derived: sum of 3 quarters · filed 2019-08-08 | -$10.03M derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | -$4.11M 10-Q · filed 2019-05-08 | -$5.57M derived: sum of 2 quarters · filed 2019-05-08 | -$8.09M derived: sum of 3 quarters · filed 2019-05-08 | -$10.56M derived: sum of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$3.97M derived: sum of 2 quarters · filed 2019-03-01 | -$6.45M derived: sum of 3 quarters · filed 2019-03-01 | -$6.47M 10-K · filed 2019-03-01 | |||
| 2017-09-30 | -$2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$5.00M derived: sum of 2 quarters · filed 2018-11-13 | -$5.02M 10-Q · filed 2018-11-13 | -$7.07M derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | -$2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$2.50M 10-Q · filed 2018-08-03 | -$4.55M derived: sum of 3 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | -$18.60K 10-Q · filed 2018-05-11 | -$2.07M derived: sum of 2 quarters · filed 2018-05-11 | |||||
| 2016-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$8.41M 10-K · filed 2018-03-02 | |||||
| 2016-09-30 | -$6.36M 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |